Venus Concept Inc. to Participate in Two Upcoming Investor Conferences on March 17th
March 11 2021 - 4:05PM
Venus Concept Inc. (“Venus Concept” or the
“Company”) (NASDAQ: VERO), a global medical aesthetic
technology leader, today announced that management will participate
in the following upcoming investor conferences in March:
The Oppenheimer 31st
Annual Healthcare Conference, which is being held virtually
from March
16th-18th.
-
Management will present on Wednesday, March 17th at 3:10 p.m.
Eastern Time.
The Maxim Emerging Growth Conference, which is being
held virtually from March
17th-18th.
-
Management’s presentation will be available on-demand beginning on
Wednesday, March 17th. The Company will also participate in a panel
discussion session titled “Maxim Group’s Virtual Aesthetic Panel”
on Wednesday, March 17th at 2:00pm Eastern time. To access the
conference presentations and panel discussions, please register
using the conference link here.
Audio webcasts of the presentations will be accessible under the
“Events” section of the Company's investor relations website at
https://ir.venusconcept.com/.
About Venus Concept
Venus Concept is an innovative global medical aesthetic
technology leader with a broad product portfolio of minimally
invasive and non-invasive medical aesthetic and hair restoration
technologies and reach in over 60 countries and 20 direct markets.
Venus Concept focuses its product sales strategy on a
subscription-based business model in North America and in its
well-established direct global markets. Venus Concept’s product
portfolio consists of aesthetic device platforms, including Venus
Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus
Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and
Venus Viva MD. Venus Concept’s hair restoration systems includes
NeoGraft®, an automated hair restoration system that facilitates
the harvesting of follicles during a FUE process and the ARTAS® and
ARTAS iX® Robotic Hair Restoration systems, which harvest
follicular units directly from the scalp and create recipient
implant sites using proprietary algorithms. Venus Concept has been
backed by leading healthcare industry growth equity investors
including EW Healthcare Partners (formerly Essex Woodlands),
HealthQuest Capital, Longitude Capital Management, and Aperture
Venture Partners.
Investor Relations Contact:
Westwicke Partners on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Apr 2023 to Apr 2024